TKT and lung carcinoma: It was used for silencing estrogen receptor alpha (ESR1), where stable knockdown suppressed the proliferation and enhanced apoptosis of breast cancer cells (82), or for silencing transketolase (TKT), which affects cell proliferation and migration as well as interactions with other metabolism-associated genes in lung cancer cells (83).